|
PSME4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49660000003937E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.5334000000018E-05 |
| Normal-vs-Stage2 |
3.957600E-03 |
| Normal-vs-Stage3 |
1.398120E-02 |
| Normal-vs-Stage4 |
1.886210E-01 |
| Stage1-vs-Stage2 |
2.182000E-01 |
| Stage1-vs-Stage3 |
4.952400E-01 |
| Stage1-vs-Stage4 |
6.066800E-01 |
| Stage2-vs-Stage3 |
8.539200E-01 |
| Stage2-vs-Stage4 |
9.193800E-01 |
| Stage3-vs-Stage4 |
8.125000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16020000000094E-05 |
| Normal-vs-AfricanAmerican |
1.166600E-04 |
| Normal-vs-Asian |
3.646300E-04 |
| Caucasian-vs-AfricanAmerican |
6.661000E-01 |
| Caucasian-vs-Asian |
3.186600E-01 |
| AfricanAmerican-vs-Asian |
3.397400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.435900E-04 |
| Normal-vs-Female |
8.91069995567761E-09 |
| Male-vs-Female |
1.176940E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.257100E-03 |
| Normal-vs-Extreme_Weight |
2.637500E-03 |
| Normal-vs-Obese |
2.982600E-04 |
| Normal-vs-Extreme_Obese |
7.630100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.343000E-01 |
| Normal_Weight-vs-Obese |
8.657600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.976200E-01 |
| Extreme_Weight-vs-Obese |
1.611030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.649600E-01 |
| Obese-vs-Extreme_Obese |
4.939800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.156600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.08109999996664E-06 |
| Normal-vs-Age(61-80Yrs) |
2.823600E-04 |
| Normal-vs-Age(81-100Yrs) |
8.551600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.210500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.197590E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.203660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.139170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.060300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.403390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.56830000000286E-05 |
| Normal-VS-Type2 PRCC |
8.360400E-02 |
| Normal-VS-KIRP CIMP |
5.72086822359097E-12 |
| Normal-VS-Unclassified PRCC |
2.598500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.479600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.57889998245275E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
4.939000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.31319999999258E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.864100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.844920E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.057500E-02 |
| Normal-vs-N1 |
1.182360E-03 |
| Normal-vs-N2 |
2.975200E-01 |
| N0-vs-N1 |
9.535900E-03 |
| N0-vs-N2 |
2.206800E-01 |
| N1-vs-N2 |
5.800200E-01 |
|
|
